Stay updated with breaking news from Barryd Stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Canadian Colorectal Cancer Coalition is launching a campaign called Save Butts, Save Lives — Take the Pledge inviting communities, organizations, and businesses of all types to Take the Pledge to sensitize their employees about the importance of colorectal cancer screening. The campaign is being launched nationally but is commencing in Quebec.
MONTREAL, May 12, 2021 /CNW/ - The Quebec – Clinical Research Organization in Cancer (Q-CROC) and Colorectal Cancer Canada (CCC) are partnering to endeavour ...
KEYTRUDA ® is an anti-PD-1 therapy that works by helping increase the ability of the body's immune system to help detect and fight tumour cells. 1 An estimated 26,900 Canadians were diagnosed with colorectal cancer in 2020, with an average of 73 Canadians diagnosed daily. 2 KIRKLAND, QC, March 8, 2021 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Health Canada has approved KEYTRUDA ® (pembrolizumab), Merck's anti-PD-1 therapy, for the first-line treatment, as monotherapy, for adult patients with metastatic microsatellite instability-hig...
Approval Based on Significant Progression Free Survival Findings from Phase 3 KEYNOTE-177 Trial KEYTRUDA ® is an anti-PD-1 therapy that works by helping increase the ability of the body’s immune system to help detect and fight tumour cells. 1 An estimated 26,900 Canadians were diagnosed with colorectal cancer in 2020, with an average of 73 Canadians diagnosed daily. 2 Merck known as MSD outside the United States … Approval Based on Significant Progression Free Survival Findings from Phase 3 KEYNOTE-177 Trial KEYTRUDA ® is an anti-PD-1 therapy that works by helping increase the a...